IPP Bureau

President of India confers Padma Shri Award on Dr. P. Vijay Anand Reddy
President of India confers Padma Shri Award on Dr. P. Vijay Anand Reddy

By IPP Bureau - May 26, 2026

The director of Apollo Cancer Centres in Hyderabad and founder of CURE Foundation honored for his contributions to cancer awareness and treatment

Dr. Ramesh Juneja joins  Alembic Pharmaceuticals as Head – India Business
Dr. Ramesh Juneja joins Alembic Pharmaceuticals as Head – India Business

By IPP Bureau - May 26, 2026

With over three decades of extensive industry experience, Ramesh Juneja brings a strong track record of building and scaling large businesses

Amgen appoints Madhur Sarin as Director – AI & Data Science COE
Amgen appoints Madhur Sarin as Director – AI & Data Science COE

By IPP Bureau - May 26, 2026

Sarin will focus on advancing scalable AI-driven platforms and strengthening the company’s global data science capabilities across healthcare and enterprise technology domains

Cornerstone Robotics secures EU CE mark and Singapore HSA approval for Sentire Surgical System
Cornerstone Robotics secures EU CE mark and Singapore HSA approval for Sentire Surgical System

By IPP Bureau - May 26, 2026

Dual regulatory clearances for Sentire(R) Endoscopic surgical system strengthen the company’s expansion across Europe and Asia-Pacific in minimally invasive robotic surgery

Lilly posts strong early clinical results for one-shot gene-editing cholesterol therapy
Lilly posts strong early clinical results for one-shot gene-editing cholesterol therapy

By IPP Bureau - May 26, 2026

A one-shot gene-editing cholesterol therapy could soon be a reality

Fredun FY26 profit jumps 60% as revenue hits Rs. 639 Cr
Fredun FY26 profit jumps 60% as revenue hits Rs. 639 Cr

By IPP Bureau - May 26, 2026

International Nurses Day 2026: WHO highlights global nursing gaps despite workforce growth
International Nurses Day 2026: WHO highlights global nursing gaps despite workforce growth

By IPP Bureau - May 26, 2026

Fresh data from the State of the World’s Nursing 2025 report shows the global nursing workforce has expanded from 27.9 million in 2018 to 29.8 million in 2023

China greenlights Boehringer Ingelheim’s HERNEXEOS for aggressive lung cancer
China greenlights Boehringer Ingelheim’s HERNEXEOS for aggressive lung cancer

By IPP Bureau - May 26, 2026

The decision clears the drug as a monotherapy for adults with unresectable, locally advanced or metastatic non-small cell lung cancer

EMA backs conditional EU nod for Vijoice in rare life-threatening overgrowth disorder PROS
EMA backs conditional EU nod for Vijoice in rare life-threatening overgrowth disorder PROS

By IPP Bureau - May 26, 2026

The company is expected to conduct further studies to confirm the long-term efficacy and safety of Vijoice in both adult and paediatric patients

Genethon and Ampersand team up to engineer next-gen gene therapy vectors with precision
Genethon and Ampersand team up to engineer next-gen gene therapy vectors with precision

By IPP Bureau - May 26, 2026

AAV vectors are widely used in gene therapy for their strong therapeutic potential

Merck’s KEYTRUDA combo wins key EU backing for bladder cancer treatment
Merck’s KEYTRUDA combo wins key EU backing for bladder cancer treatment

By IPP Bureau - May 25, 2026

The decision now moves to the European Commission, with a final ruling expected by the third quarter of 2026

Datroway wins US nod in aggressive breast cancer subtype
Datroway wins US nod in aggressive breast cancer subtype

By IPP Bureau - May 25, 2026

Clearance marks major shift beyond chemotherapy

Oral GLP-1 race heats up as Lilly’s Foundayo shines in seniors
Oral GLP-1 race heats up as Lilly’s Foundayo shines in seniors

By IPP Bureau - May 25, 2026

The company said all doses achieved statistically significant reductions in body weight compared with placebo at 72 weeks

AbbVie scores key EU backing for Hepatitis C drug in push for earlier treatment
AbbVie scores key EU backing for Hepatitis C drug in push for earlier treatment

By IPP Bureau - May 25, 2026

If cleared, MAVIRET would become one of the few therapies in the European Union approved to treat both acute and chronic hepatitis C infections

WHO declares Ebola outbreak, Indians advised against travel to affected regions
WHO declares Ebola outbreak, Indians advised against travel to affected regions

By IPP Bureau - May 25, 2026

No approved vaccine or specific treatment currently available for Bundibugyo strain Ebola disease

Latest Stories

Interviews

Packaging